Cited by 14Metabolomics and Mass Spectrometry StudiesAdrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Novel methods in adrenal research: a metabolomics approach

Papathomas, Thomas G., Sun, Na, Chortis, Vasileios, Taylor, Angela E., Arlt, Wiebke, Richter, Susan, Eisenhofer, Graeme, Ruiz-Babot, Gerard +2 more·2019·Histochemistry and Cell Biology

Abstract

Metabolic alterations have implications in a spectrum of tissue functions and disease. Aided by novel molecular biological and computational tools, our understanding of physiological and pathological processes underpinning endocrine and endocrine-related disease has significantly expanded over the last decade. Herein, we focus on novel metabolomics-related methodologies in adrenal research: in situ metabolomics by mass spectrometry imaging, steroid metabolomics by gas and liquid chromatography-mass spectrometry, energy pathway metabologenomics by liquid chromatography-mass spectrometry-based metabolomics of Krebs cycle intermediates, and cellular reprogramming to generate functional steroidogenic cells and hence to modulate the steroid metabolome. All four techniques to assess and/or modulate the metabolome in biological systems provide tremendous opportunities to manage neoplastic and non-neoplastic disease of the adrenal glands in the era of precision medicine. In this context, we discuss emerging clinical applications and/or promising metabolic-driven research towards diagnostic, prognostic, predictive and therapeutic biomarkers in tumours arising from the adrenal gland and extra-adrenal paraganglia as well as modern approaches to delineate and reprogram adrenal metabolism.

Integrity signals

Registry

Crossref · 10.1007/s00418-019-01772-w

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Specificity rates of 85% to 89% for metanephrine testing decrease to 77% in elderly people and can be improved by using age-adjusted reference ranges.

    “Specificity rates of 85% to 89% decrease to 77% in elderly people and can be improved by using age-adjusted reference ranges (204-206).”

    From Adrenal incidentaloma (2020) · cites this paper as [206]

  • LC-MS/MS is considerably faster and less labor intensive and allows much higher throughput than GC-MS.

    “LC-MS/MS is considerably faster and less labor intensive and allows a much higher throughput than GC-MS; however, LC-MS/MS has a poorer resolving capacity (206).”

    From Adrenal incidentaloma (2020) · cites this paper as [206]

  • In mass spectrometry, steroids are identified by unique retention times and/or multiple reaction monitoring, and the area under the peak in the chromatogram is proportional to concentration and quantifiable via comparison to standard reference materials.

    “In mass spectrometry, steroids are identified by unique retention times and or multiple reaction monitoring (206) with the area under the peak in the chromatogram is proportional to its concentration and quantifiable via comparison to standard reference materials of known concentration.”

    From Adrenal incidentaloma (2020) · cites this paper as [206]

  • LC-MS/MS is more suited to a smaller panel of corticosteroids and their metabolites and does not have the same broad scope of analysis as GC-MS.

    “As a result, LC-MS/MS is more suited to a smaller panel of corticosteroids and their metabolites and as a result does not have the same broad scope of analysis that GC-MS allows (206).”

    From Adrenal incidentaloma (2020) · cites this paper as [206]

  • LC-MS/MS has poorer resolving capacity than GC-MS.

    “LC-MS/MS is considerably faster and less labor intensive and allows a much higher throughput than GC-MS; however, LC-MS/MS has a poorer resolving capacity (206).”

    From Adrenal incidentaloma (2020) · cites this paper as [206]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Papathomas, T. G., Sun, N., Chortis, V., Taylor, A. E., Arlt, W., Richter, S., Eisenhofer, G., Ruiz-Babot, G., Guasti, L., & Walch, A. K.
Affiliations
  • Helmholtz Munich (DE)
  • University of Birmingham (GB)
  • University Hospital Carl Gustav Carus (DE)
  • Queen Mary University of London (GB)
Corresponding author
Walch, Axel Karl
Venue
Histochemistry and Cell Biology
Published
2019-02-06
Volume
151
Issue
3
Pages
201-216
ISSN
  • 0948-6143 (ISSN-L)
  • 1432-119X
OpenAlex
W2912874287
Cited by
14
References
137
Citations by year
2024: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 1
FWCI
0.18
Type
journal article
Language
en
Open access
closed
Locations
  • Histochemistry and Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Site cant be reached (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (SFB 824 C4, CRC/Transregio 205/1, CRC/Transregio 205)
  • Pathological Society of Great Britain and Ireland (PathSoc 2018 Visiting Fellowship/Grant Reference No: 1183)
  • Deutsche Krebshilfe (70112617)
  • German Federal Ministry of Education and Research (BMBF, 01ZX1210B, 01KT1615)
  • The Paradifference foundation
  • Academy of Medical Sciences (Starter Grant for Clinical Lecturers)
  • European Commission Horizon 2020 Programme (633893 (ENSAT-HT))
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
adrenal gland, adrenal tumors, adrenal paraganglioma, mass spectrometry imaging, Krebs cycle intermediates, cellular reprogramming, steroidogenic cells, metabolic biomarkers, precision medicine
MeSH terms
Adrenal Glands, Animals, Chromatography, Liquid, Humans, Mass Spectrometry, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review